OKYO Pharma logo

OKYO - OKYO Pharma News Story

10.13p -0.1  -1.2%

Last Trade - 18/09/20

Small Cap
Market Cap £64.4m
Enterprise Value £64.3m
Revenue £n/a
Position in Universe 1091st / 1807

OKYO Pharma Corp - Change of Broker

Fri 2nd March, 2018 12:47pm
RNS Number : 5622G
OKYO Pharma Corporation
02 March 2018

For immediate release

2 March 2018

Okyo Pharma Corporation
("Okyo" or the "Company")

Change of Broker

The Company notes the announcement today regarding Beaufort Securities Limited ("BSL") and Beaufort Asset Clearing Services Limited ("BACSL") being placed into insolvency and that the Financial Conduct Authority (the "FCA") has imposed requirements on BSL and BACSL to cease all regulatory activity.

BSL is the broker to the Company pursuant to the AIM Rules for Companies (the "AIM Rules"). As a result of the requirements imposed by the FCA, BSL will no longer be able to provide broking services to the Company in accordance with the AIM Rules.

The Company is seeking to appoint a new broker as soon as possible and a further announcement will be made when this appointment is made.

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse.


Okyo Pharma Corporation

Willy Simon, Chariman


Beaumont Cornish

Michael Cornish

Roland Cornish

+44 (0)207628 3369

Email: corpfin@b-cornish.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.